ONLY 2 WEEKS UNTIL THE CONFERENCE!
InMed Pharmaceuticals is a leader in the manufacturing and development of rare cannabinoids. InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates and is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. InMed is also developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids and recently announced a definitive agreement to acquire BayMedica, a leader in the commercialization and manufacture of rare cannabinoids.
The Benzinga Cannabis Capital Conference is back this September 13-14 at the Palmer House in Chicago, IL.
Join us to discover the newest and hottest in cannabis, meet investors and CEOs of leading public and private companies and network with 90% of publicly traded cannabis companies, all in one room.
To enter a promo code, please click the "Enter promo code" link below.